{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:15:12Z","timestamp":1791008112468,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.nbd.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T05:12:16Z","timestamp":1248412336000},"page":"151-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evidence of molecular links between PKR and mTOR signalling pathways in A\u03b2 neurotoxicity: Role of p53, Redd1 and TSC2"],"prefix":"10.1016","volume":"36","author":[{"given":"Milena","family":"Morel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pontcharraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fauconneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Paccalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyl\u00e8ne","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.07.004_bib1","doi-asserted-by":"crossref","first-page":"31675","DOI":"10.1074\/jbc.M704491200","article-title":"The eIF2alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53","volume":"282","author":"Baltzis","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2008.03.015","article-title":"Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease","volume":"45","author":"Cenini","year":"2008","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.nbd.2009.07.004_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1582-4934.2008.00163.x","article-title":"Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease","volume":"12","author":"Cenini","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1471-4159.2002.01237.x","article-title":"Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration","volume":"83","author":"Chang","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.07.004_bib6","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/00001756-200212200-00011","article-title":"Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease","volume":"13","author":"Chang","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2009.07.004_bib7","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/sj.onc.1204373","article-title":"The role of tetramerization in p53 function","volume":"20","author":"Chene","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1038\/sj.onc.1207544","article-title":"Targets and mechanisms for the regulation of translation in malignant transformation","volume":"23","author":"Clemens","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2009.07.004_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/jir.1997.17.503","article-title":"The double-stranded RNA-dependent protein kinase PKR: structure and function","volume":"17","author":"Clemens","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"9769","DOI":"10.1074\/jbc.C400557200","article-title":"The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway","volume":"280","author":"Corradetti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/sj.onc.1202620","article-title":"The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro","volume":"18","author":"Cuddihy","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2009.07.004_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nbd.2007.09.008","article-title":"Dissociation of Akt\/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer's disease","volume":"29","author":"Damjanac","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.07.004_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"DeYoung","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2009.07.004_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4161\/cc.4.11.2139","article-title":"Growth control under stress: mTOR regulation through the REDD1-TSC pathway","volume":"4","author":"Ellisen","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nbd.2009.07.004_bib16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(02)00706-2","article-title":"REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species","volume":"10","author":"Ellisen","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2009.07.004_bib17","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.07.004_bib18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-4157(91)90013-M","article-title":"Nuclear protein localization","volume":"1071","author":"Garcia-Bustos","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2009.07.004_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/MMBR.69.1.79-100.2005","article-title":"Signaling by target of rapamycin proteins in cell growth control","volume":"69","author":"Inoki","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.nbd.2009.07.004_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/excr.1995.1126","article-title":"Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells","volume":"218","author":"Jeffrey","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.cellsig.2006.12.014","article-title":"Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"19","author":"Jin","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.nbd.2009.07.004_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/NMM:7:4:287","article-title":"Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway","volume":"7","author":"Jozwiak","year":"2005","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.nbd.2009.07.004_bib24","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1074\/jbc.M706643200","article-title":"Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis","volume":"283","author":"Kimball","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/emm.2003.53","article-title":"Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity","volume":"35","author":"Kim","year":"2003","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.nbd.2009.07.004_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0898-6568(03)00040-8","article-title":"Tumour suppressors hamartin and tuberin: intracellular signalling","volume":"15","author":"Krymskaya","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.nbd.2009.07.004_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease","volume":"94","author":"Lafay-Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.07.004_bib28","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jnr.21039","article-title":"The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide","volume":"84","author":"Lafay-Chebassier","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2007-12109","article-title":"Unfolded p53: a potential biomarker for Alzheimer's disease","volume":"12","author":"Lanni","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2009.07.004_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: a novel Alzheimer's disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2009.07.004_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","article-title":"The complexity of p53 stabilization and activation","volume":"13","author":"Lavin","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2009.07.004_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/gad.1363206","article-title":"Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways","volume":"20","author":"Levine","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2009.07.004_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004410100396","article-title":"Neuronal apoptosis at the G1\/S cell cycle checkpoint","volume":"305","author":"Liu","year":"2001","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib34","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/00001756-200410050-00019","article-title":"Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain","volume":"15","author":"Li","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2009.07.004_bib35","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","article-title":"Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain","volume":"272","author":"Li","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2009.07.004_bib36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0197-4580(00)00223-2","article-title":"Cell cycle regulatory failure in neurones: causes and consequences","volume":"21","author":"Nagy","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2009.07.004_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2005.09.005","article-title":"The cell cycle as a therapeutic target for Alzheimer's disease","volume":"111","author":"Neve","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2009.07.004_bib38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.emboj.7600049","article-title":"An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease","volume":"23","author":"Onuki","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2009.07.004_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.cdd.4401923","article-title":"Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint","volume":"13","author":"Opferman","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2009.07.004_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2006.07.053","article-title":"Peripheral p70S6k levels and emotional memory in patients with Alzheimer's disease","volume":"410","author":"Paccalin","year":"2006","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.nbd.2009.07.004_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000095562","article-title":"Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease","volume":"22","author":"Paccalin","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2009.07.004_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.neuroscience.2006.01.047","article-title":"Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease","volume":"139","author":"Page","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2009.07.004_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnen\/63.2.97","article-title":"PKR activation in neurodegenerative disease","volume":"63","author":"Peel","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.07.004_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0969-9961(03)00086-X","article-title":"Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice","volume":"14","author":"Peel","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.07.004_bib45","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer's disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2009.07.004_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4933-5-7","article-title":"Alzheimer's disease: new diagnostic and therapeutic tools","volume":"5","author":"Racchi","year":"2008","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.nbd.2009.07.004_bib47","doi-asserted-by":"crossref","first-page":"54518","DOI":"10.1074\/jbc.M408186200","article-title":"Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis","volume":"279","author":"Rametti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib48","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.121145898","article-title":"The target of rapamycin (TOR) proteins","volume":"98","author":"Raught","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.07.004_bib49","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/MCB.18.4.2282","article-title":"Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2","volume":"18","author":"Romano","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2009.07.004_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","article-title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners","volume":"658","author":"Rosner","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.nbd.2009.07.004_bib51","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/MCB.22.7.2283-2293.2002","article-title":"Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis","volume":"22","author":"Shoshani","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2009.07.004_bib52","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1074\/jbc.C200499200","article-title":"14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin","volume":"278","author":"Shumway","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib53","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1128\/MCB.25.14.5834-5845.2005","article-title":"Regulation of mTOR and cell growth in response to energy stress by REDD1","volume":"25","author":"Sofer","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2009.07.004_bib54","doi-asserted-by":"crossref","first-page":"49819","DOI":"10.1074\/jbc.M306503200","article-title":"Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine\/threonine protein kinase in beta-amyloid peptide neurotoxicity","volume":"278","author":"Suen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib55","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1242\/jcs.115.15.3131","article-title":"Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients","volume":"115","author":"Uberti","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2009.07.004_bib56","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neurobiolaging.2005.06.013","article-title":"Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients","volume":"27","author":"Uberti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2009.07.004_bib57","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1471-4159.2007.04757.x","article-title":"Over-expression of amyloid precursor protein in HEK cells alters p53 conformational state and protects against doxorubicin","volume":"103","author":"Uberti","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.07.004_bib58","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","article-title":"Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.07.004_bib59","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","article-title":"PKR; a sentinel kinase for cellular stress","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109001776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109001776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:05:40Z","timestamp":1760850340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109001776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0969996109001776"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.07.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of molecular links between PKR and mTOR signalling pathways in A\u03b2 neurotoxicity: Role of p53, Redd1 and TSC2","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}